The Liberal Democrats have called on the government to abandon a controversial pharmaceutical agreement with the United States, arguing that the savings should instead be invested in England’s struggling social care sector.
Under the current arrangement, UK pharmaceutical products will continue to enter the US market without tariffs for a three-year period. The agreement requires the NHS to increase its cost threshold for new medications by a quarter.
Daisy Cooper, the party’s deputy leader, has been critical of the deal’s financial implications, suggesting the expenditure represents poor value for money that could have been directed towards care services.
The Liberal Democrats are pressing Prime Minister Sir Keir Starmer to take personal charge of cross-party talks on social care reform. Despite announcements made a year ago about establishing dialogue on the sector’s future, the party claims that Baroness Casey’s independent commission on adult social care has convened just once for cross-party discussions.
Estimates of the deal’s cost to the NHS have varied considerably. Whilst some reports have suggested annual costs could reach £3 billion, both Downing Street and Health Secretary Wes Streeting have indicated the actual figure would be closer to £1 billion by spring 2029.
Ms Cooper stated that urgent action was needed to address what she described as a crisis in care provision. She emphasised that families continue to experience difficulties with a system she characterised as inadequate, whilst hospital capacity remains affected by delayed discharges.
Government Response
Government representatives have rejected claims that the pharmaceutical agreement will cost £3 billion, insisting that frontline NHS services will not face funding cuts to accommodate the deal.
A spokesperson defended the arrangement as an important investment that leverages Britain’s pharmaceutical sector whilst improving access to treatments. They acknowledged inheriting significant challenges around hospital discharge following previous administrations.
The government pointed to increased appointment availability and improving NHS productivity as evidence of progress. Officials stated they are collaborating with Baroness Casey on care sector reforms whilst working to better integrate NHS and social care services.
Measures being implemented include updated guidance on hospital discharge procedures and the development of neighbourhood health teams designed to deliver more care in community settings.
The ongoing debate reflects wider concerns about social care funding in England, where the sector has faced sustained pressure from workforce shortages, rising demand, and financial constraints affecting both providers and local authorities.
